JP2010500331A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500331A5
JP2010500331A5 JP2009523312A JP2009523312A JP2010500331A5 JP 2010500331 A5 JP2010500331 A5 JP 2010500331A5 JP 2009523312 A JP2009523312 A JP 2009523312A JP 2009523312 A JP2009523312 A JP 2009523312A JP 2010500331 A5 JP2010500331 A5 JP 2010500331A5
Authority
JP
Japan
Prior art keywords
octapeptins
residues
polymyxins
acid
natural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009523312A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010500331A (ja
JP5226685B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2007/050441 external-priority patent/WO2008017734A1/en
Publication of JP2010500331A publication Critical patent/JP2010500331A/ja
Publication of JP2010500331A5 publication Critical patent/JP2010500331A5/ja
Application granted granted Critical
Publication of JP5226685B2 publication Critical patent/JP5226685B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009523312A 2006-08-11 2007-08-10 ポリミキシン誘導体およびその使用 Expired - Fee Related JP5226685B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US83742606P 2006-08-11 2006-08-11
US60/837,426 2006-08-11
DKPA200601055 2006-08-11
DKPA200601055 2006-08-11
PCT/FI2007/050441 WO2008017734A1 (en) 2006-08-11 2007-08-10 Polymyxin derivatives and uses thereof

Publications (3)

Publication Number Publication Date
JP2010500331A JP2010500331A (ja) 2010-01-07
JP2010500331A5 true JP2010500331A5 (enExample) 2010-08-12
JP5226685B2 JP5226685B2 (ja) 2013-07-03

Family

ID=39032653

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009523312A Expired - Fee Related JP5226685B2 (ja) 2006-08-11 2007-08-10 ポリミキシン誘導体およびその使用

Country Status (21)

Country Link
EP (2) EP3078672A1 (enExample)
JP (1) JP5226685B2 (enExample)
KR (2) KR20150008198A (enExample)
CN (2) CN101501063B (enExample)
AU (1) AU2007283514B2 (enExample)
BR (1) BRPI0715095B8 (enExample)
CA (1) CA2694289C (enExample)
CY (1) CY1117848T1 (enExample)
DK (1) DK2057185T3 (enExample)
ES (1) ES2575521T3 (enExample)
HR (1) HRP20160552T1 (enExample)
HU (1) HUE028271T2 (enExample)
IL (2) IL196693B (enExample)
MX (1) MX2009001398A (enExample)
NO (1) NO341982B1 (enExample)
NZ (1) NZ575421A (enExample)
PL (1) PL2057185T3 (enExample)
PT (1) PT2057185E (enExample)
RU (1) RU2455311C2 (enExample)
SI (1) SI2057185T1 (enExample)
WO (1) WO2008017734A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
FI20085469A0 (fi) * 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
TW201035111A (en) 2008-12-23 2010-10-01 Biosource Pharm Inc Antibiotic compositions for the treatment of gram negative infections
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (en) * 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
BR112014012016A2 (pt) * 2011-11-18 2017-05-16 Cantab Anti-Infectives Ltd compostos
JP6643758B2 (ja) 2013-05-22 2020-02-12 スペロ・セラピューティクス・インコーポレーテッド 異なった抗生物質と一緒の組合せ療法におけるポリミキシン誘導体及びその使用
RU2740190C2 (ru) * 2014-03-11 2021-01-12 Сперо Терапьютикс, Инк. Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками
KR101664106B1 (ko) 2014-09-11 2016-10-10 한국화학연구원 폴리믹신 b 화합물을 포함하는 심혈관 질환의 예방 및 치료용 약학적 조성물
CN107108699A (zh) * 2014-11-26 2017-08-29 新药物许可控股有限公司 化合物
US9771394B2 (en) 2014-12-16 2017-09-26 Micurx Pharmaceuticals, Inc. Antimicrobial polymyxins for treatment of bacterial infections
CN107530397A (zh) * 2014-12-18 2018-01-02 赫尔普百治疗有限公司 新型组合和用途
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
US9763996B2 (en) 2015-01-16 2017-09-19 Northern Antibiotics, Ltd. Polymyxin derivative and uses thereof
CN104672307B (zh) * 2015-03-23 2017-09-29 吉林大学 一种提高阳离子短肽抗菌性和稳定性的方法
EP3072956A1 (en) * 2015-03-25 2016-09-28 Université de Fribourg Selective culture medium for polymyxin-resistant, gram-negative bacteria
FR3036406B1 (fr) 2015-05-20 2019-07-19 Biomerieux Identification des bacteries resistantes aux carbapenemes par impermeabilite membranaire
EP3374027B1 (en) * 2015-11-12 2021-06-23 The Trustees of Columbia University in the City of New York Rational drug design targeting resistant gram-negative bacterial infections to polymyxin-class antibiotics
WO2017189866A1 (en) * 2016-04-27 2017-11-02 Spero Opco Polymyxin analogs useful as antibiotic potentiators
WO2017189868A1 (en) * 2016-04-27 2017-11-02 Spero Opco Serine replacement polymyxin analogues useful as antibiotic potentiators
GB201703898D0 (en) 2017-03-10 2017-04-26 Helperby Therapeautics Ltd Method
GB201704620D0 (en) 2017-03-23 2017-05-10 Helperby Therapeautics Ltd Combinations
AU2018359018B2 (en) * 2017-11-02 2022-11-24 The University Of Queensland Peptide antibiotics
EP3560489A1 (en) * 2018-04-27 2019-10-30 European Molecular Biology Laboratory Pharmaceutical compositions for prevention and/or treatment of infections and antibacterial-induced dysfunctions
MD3810633T2 (ro) 2018-06-25 2024-05-31 Spero Therapeutics Inc Compuşi
CN112739710B (zh) * 2018-07-19 2024-08-27 东北大学 具有抗菌特性的化合物
CN110179967A (zh) * 2019-05-28 2019-08-30 中国医药集团总公司四川抗菌素工业研究所 多粘菌素母核和一种抗生素的组合物及其应用
IT201900025414A1 (it) 2019-12-23 2021-06-23 Univ Bologna Alma Mater Studiorum Composto per il trattamento della sindrome emolitico uremica
WO2021150792A1 (en) 2020-01-21 2021-07-29 Micurx Pharmaceuticals, Inc. Novel compounds and composition for targeted therapy of kidney-associated cancers
CN118028502B (zh) * 2022-08-30 2024-07-26 四川大学华西医院 一类phoQ基因突变体、应用及其验证方法
WO2024123712A1 (en) * 2022-12-04 2024-06-13 Genentech, Inc. Analysis of candidate cytotoxic compositions
CN120399010B (zh) * 2025-07-01 2025-09-12 杭州肽佳生物科技有限公司 抗生素多粘菌素的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450687A (en) 1966-02-24 1969-06-17 Pfizer & Co C Lower alkanoyl esters of polymyxin antibiotics
JPS4915537B1 (enExample) 1970-03-25 1974-04-16
BE754411A (fr) 1969-08-05 1971-02-04 Rhone Poulenc Sa Cyclopeptides derives des polymyxines et leur
GB2128617A (en) 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
DE60130359T2 (de) * 2000-11-20 2008-06-26 Daiichi Sankyo Co., Ltd. Deshalogenverbindungen
WO2002055543A2 (en) 2001-01-16 2002-07-18 Univ Ramot Hybrid peptides for treatment of bacteremia and septicemia
DE60217060T2 (de) * 2002-03-01 2007-06-21 Chiesi Farmaceutici S.P.A. Pharmazeutische Zusammensetzungen, die Lungensurfactants und ein Polymyxin umfassen und verbesserte Oberflächenspannung-senkende Eigenschaften haben
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion

Similar Documents

Publication Publication Date Title
JP2010500331A5 (enExample)
CY1113858T1 (el) Παραγωγα πυριδιν-3-υλιου ως ανοσορυθμιστικοι παραγοντες
WO2010033444A8 (en) Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
JP2010525017A5 (enExample)
CL2007001993A1 (es) Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat
JP2009535462A5 (enExample)
MA32812B1 (fr) Composition pharmaceutique d'un inhibiteur puissant du vhc pour une administration orale
CL2007001131A1 (es) Compuestos derivados de purina sustituida; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias.
CL2007003690A1 (es) Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas.
JP2007522094A5 (enExample)
WO2009066315A3 (en) Sustained release compositions of trimetazidine and process for preparation thereof
WO2008153159A1 (ja) アミン化合物及びその医薬用途
CL2007003519A1 (es) Compuestos derivados de quinolina sustituida; proceso de preparacion; compuesto intermediario; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
CY1114364T1 (el) Φαρμακευτικες συνθεσεις για την θεραπεια της αρτηριοπαθειας των τριχοειδων αγγειων
JP2008515980A5 (enExample)
TW200503703A (en) Pharmaceutical compositions
JP2008519810A5 (enExample)
JP2008539169A5 (enExample)
JP2011012060A5 (enExample)
JP2012501302A5 (enExample)
JP2007217514A5 (enExample)
CL2007003518A1 (es) Compuestos derivados de quinolina sustituida; proceso de preparacion; compuesto intermediario; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
ATE407126T1 (de) Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on
JP2009509934A5 (enExample)
JP2007508806A5 (enExample)